Suchergebnisse - "Jinbing Zhu"

PubPharm (4)

1

Efficacy and safety of bispecific antibodies therapy for relapsed or refractory multiple myeloma: a systematic review and meta-analysis of prospective clinical trials

in: Frontiers in Immunology | 2024

von Xin Wang | Ailin Zhao | Jinbing Zhu | +1

2

P1009: SKLB054, A NOVEL JAK2 INHIBITOR, POTENTLY TREATS MYELOPROLIFERATIVE NEOPLASM WITH JAK2V617F MUTATION

in: HemaSphere | 2023

von Ailin Zhao | Tao Yang | Linyu Yang | +8

3

Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2 V617F-induced myeloproliferative neoplasms

in: Blood Cancer Journal | 2022

von Mengshi Hu | Tao Yang | Linyu Yang | +13

4

Risk of Bleeding Associated With Ibrutinib in Patients With B-Cell Malignancies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

in: Frontiers in Pharmacology | 2020

von Jinjin Wang | Ailin Zhao | Hui Zhou | +2

1
[1]